| LIFEGENE- BIOMARKS, INC | US | unknown | $1.5M |
| Lifeward Ltd. | US | unknown | $20.0M |
| Lingokids | ES | series-b+ | $170.0M |
| LiquidX | US | unknown | $3.5M |
| Lotus Health | US | series-a | $41.0M |
| Low Observable Technology | GB | seed | $4.6M |
| Lucem Health, Inc. | US | unknown | $2.3M |
| LUMENA INC | US | unknown | $1.8M |
| Luminary Therapeutics, Inc. | US | unknown | $12.4M |
| Lutris, INC. | US | series-b+ | $1.2M |
| LynXes Innovation | HU | unknown | $2.7M |
| MAGEE TECHNOLOGIES LLC | US | unknown | $1.6M |
| Makersite | DE | series-b+ | $81.0M |
| Managed Health Connections, Inc. | US | unknown | $2.7M |
| MANAGEMENT SCIENCES INC | US | unknown | $1.9M |
| Marker Therapeutics, Inc. | US | unknown | $2.0M |
| MARTINEAU & ASSOCIATES | US | unknown | $2.0M |
| Matteco | ES | series-a | $17.3M |
| MATTRIX TECHNOLOGIES, INC. | US | unknown | $1.9M |
| MAVERICK CORPORATION | US | unknown | $1.8M |
| Max Retail | US | series-a | $15.0M |
| MAYFLOWER COMMUNICATIONS COMPANY, INC. | US | unknown | $2.0M |
| Mazama | US | seed | $1.0M |
| Mbryonics | IE | unknown | $2.7M |
| MD Ally | US | series-a | $14.0M |
| Med AI Diagnostics | US | unknown | $1.0M |
| MEDICAL CYBERWORLDS, INC. | US | unknown | $2.0M |
| MedVector Corp | US | unknown | $1.0M |
| Memfault | US | series-a | $5.0M |
| Mente Systems Inc. | US | unknown | $2.5M |
| MERCATOR MEDSYSTEMS, INC. | US | unknown | $2.7M |
| Merida Biosciences | US | series-a | $121.0M |
| MERLIN THERAPEUTICS INC | US | unknown | $1.3M |
| MESA PHOTONICS LLC | US | unknown | $1.6M |
| MetaCTF, Inc. | US | unknown | $1.0M |
| METROLASER, INCORPORATED | US | unknown | $1.5M |
| Meva Energy | SE | series-b+ | $43.2M |
| MiAI Law | unknown | seed | $1.3M |
| MICROCURES INC | US | unknown | $1.4M |
| Microgen LLC | US | unknown | $3.0M |
| MICROSURGEONBOT INC | US | unknown | $1.2M |
| Micruity | US | series-a | $19.0M |
| Mightyfly Inc | US | unknown | $1.2M |
| Mile Two LLC | US | unknown | $1.8M |
| MILESTONE SCIENTIFIC INC. | US | unknown | $2.1M |
| MIMETICS, LLC | US | unknown | $1.4M |
| MiNDERA Corp | US | unknown | $25.4M |
| MIRAVISTA DIAGNOSTICS LLC | US | unknown | $3.0M |
| MIRECULE INC | US | unknown | $2.4M |
| Mitra Bio | GB | unknown | $127,800 |
| Mitra Bio | GB | series-b+ | $2.7M |
| Momants | NL | unknown | $1.1M |
| MOMENTUS SPACE LLC | US | unknown | $1.9M |
| MonuMedical LLC | US | unknown | $1.2M |
| MORE COWBELL UNLIMITED, INC | US | unknown | $2.0M |
| MORPHOPTIC INC | US | unknown | $1.5M |
| Mosanna Therapeutics | CH | series-a | $80.0M |
| MOTIV SPACE SYSTEMS, INC. | US | unknown | $4.0M |
| MRL MATERIALS RESOURCES LLC | US | unknown | $2.0M |
| MTRI INC, dba Balto Innovations | US | unknown | $1.2M |
| Muffin | IT | pre-seed | $3.5M |
| Multi-Domain Global Solutions LLC | US | unknown | $1.2M |
| Muse Software Inc. | US | unknown | $2.6M |
| MYOLEX, INC. | US | unknown | $2.0M |
| Myopax | DE | unknown | $2.7M |
| Myrtelle Inc. | US | unknown | $55.2M |
| N-Fix | BE | unknown | $2.7M |
| NADMED | FI | series-a | $3.8M |
| NANO COMPOSITE PRODUCTS, INC | US | unknown | $1.9M |
| Nano-Tech | IT | unknown | $2.7M |
| NANOIONIX, LLC | US | unknown | $1.8M |
| NANOMETICS LLC | US | unknown | $2.0M |
| NanoPhoria | IT | series-a | $90.2M |
| NANOSPERSE LLC | US | unknown | $1.7M |
| NanoXplore | FR | series-b+ | $21.6M |
| Naratix | RO | seed | $1.2M |
| NATRX INC | US | unknown | $1.8M |
| NCX CORPORATION | US | unknown | $1.2M |
| Nearfield Instruments | NL | unknown | $2.7M |
| Neela Therapeutics | US | unknown | $12.0M |
| NEI CORPORATION | US | unknown | $1.3M |
| NEOEX SYSTEMS, INC. | US | unknown | $3.6M |
| Nephropathology Associates, PLC | US | unknown | $1.9M |
| Nerdio | US | series-b+ | $625.0M |
| NETRISE INC | US | unknown | $1.8M |
| Neura Robotics | DE | series-b+ | $129.6M |
| NeuRescue | DK | unknown | $2.7M |
| NEUREXIS THERAPEUTICS, INC. | US | unknown | $2.8M |
| Neurinnov | FR | unknown | $2.7M |
| Neurolux, Inc. | US | unknown | $2.0M |
| Neuron23 | US | series-b+ | $310.0M |
| Neuroptics, Inc. | US | unknown | $2.4M |
| Neuros Medical | US | series-b+ | $56.0M |
| Neurovalens | GB | series-a | $21.6M |
| Nexben | US | unknown | $28.2M |
| Nexo Therapeutics, Inc. | US | unknown | $60.0M |
| Next Sense | NL | series-a | $12.4M |
| NEXT TIER CONCEPTS INC | US | unknown | $2.0M |
| NEXTGEN AERONAUTICS, INC. | US | unknown | $3.0M |
| NextKidney | NL | unknown | $2.7M |